Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Should Activision Blizzard's Investors Be Worried About "Destiny 2" Sales?
Should Activision Blizzard's Investors Be Worried About "Destiny 2" Sales?
Activision Blizzard (NASDAQ: ATVI) recently published a press release touting the first-week performance of Destiny 2. However, the document contained no actual sales figures, and the only....
Should Activision Blizzard's Investors Be Worried About "Destiny 2" Sales?
Should Activision Blizzard's Investors Be Worried About "Destiny 2" Sales?
Activision Blizzard (NASDAQ: ATVI) recently published a press release touting the first-week performance of Destiny 2. However, the document contained no actual sales figures, and the only....
Don't Buy the "Death of ESPN" Hype
Don't Buy the "Death of ESPN" Hype
For much of the last three years, shares of The Walt Disney Company (NYSE: DIS) have been range bound, primarily on investor fears involving the future of its flagship ESPN sports network. From a....
3 Big Biotech Stocks to Buy This Fall
3 Big Biotech Stocks to Buy This Fall
A change in season presents a good time to look for great stocks to buy. And one of the best places to look is in the biotech industry. Biotech stocks in general are trouncing the S&P 500....
3 High-Yield Dividend Giants Still Worth Owning
3 High-Yield Dividend Giants Still Worth Owning
Many investors want to have their investment portfolios generate income, either to provide more investment capital for further stock purchases or to cover regular living expenses. High-yield....
Is Plug Power, Inc. a Buy?
Is Plug Power, Inc. a Buy?
Like solar and wind power, many alternative energy advocates have touted the potential of hydrogen power for years. Investors in fuel cell companies like Plug Power (NASDAQ: PLUG) are still....
Is Plug Power, Inc. a Buy?
Is Plug Power, Inc. a Buy?
Like solar and wind power, many alternative energy advocates have touted the potential of hydrogen power for years. Investors in fuel cell companies like Plug Power (NASDAQ: PLUG) are still....
Is Plug Power, Inc. a Buy?
Is Plug Power, Inc. a Buy?
Like solar and wind power, many alternative energy advocates have touted the potential of hydrogen power for years. Investors in fuel cell companies like Plug Power (NASDAQ: PLUG) are still....
Better Buy: Freeport-McMoRan Inc vs. Vale SA
Better Buy: Freeport-McMoRan Inc vs. Vale SA
The commodity downturn that started in 2011 was tough on mining industry giants Freeport-McMoRan Inc (NYSE: FCX) and Vale SA (NYSE: VALE). Both were left bleeding red ink and forced to sell assets....
It's Time for AeroVironment to Break Up
It's Time for AeroVironment to Break Up
After years of ups and downs, AeroVironment, Inc. (NASDAQ: AVAV) appears to be firing on all cylinders. The company's drones are growing in both military and commercial applications and its....
Ask a Fool! We Answer Your Healthcare Questions on Trials, Patents, and Pharmacy Retailers
Ask a Fool! We Answer Your Healthcare Questions on Trials, Patents, and Pharmacy Retailers
If you've ever wondered why drugmakers run Phase I-II or II B clinical trials, how drugmakers like AbbVie (NYSE: ABBV) plan on keeping generic drugmakers at bay after their patents expire, or why....
Ask a Fool! We Answer Your Healthcare Questions on Trials, Patents, and Pharmacy Retailers
Ask a Fool! We Answer Your Healthcare Questions on Trials, Patents, and Pharmacy Retailers
If you've ever wondered why drugmakers run Phase I-II or II B clinical trials, how drugmakers like AbbVie (NYSE: ABBV) plan on keeping generic drugmakers at bay after their patents expire, or why....
Ask a Fool! We Answer Your Healthcare Questions on Trials, Patents, and Pharmacy Retailers
Ask a Fool! We Answer Your Healthcare Questions on Trials, Patents, and Pharmacy Retailers
If you've ever wondered why drugmakers run Phase I-II or II B clinical trials, how drugmakers like AbbVie (NYSE: ABBV) plan on keeping generic drugmakers at bay after their patents expire, or why....
Ask a Fool! We Answer Your Healthcare Questions on Trials, Patents, and Pharmacy Retailers
Ask a Fool! We Answer Your Healthcare Questions on Trials, Patents, and Pharmacy Retailers
If you've ever wondered why drugmakers run Phase I-II or II B clinical trials, how drugmakers like AbbVie (NYSE: ABBV) plan on keeping generic drugmakers at bay after their patents expire, or why....
Is Weibo's Growth Just Getting Started?
Is Weibo's Growth Just Getting Started?
Weibo (NASDAQ: WB) stock has been on a tear in 2017, with shares up roughly 160% year to date as of this writing, trading at all-time highs. With an expanding user base and ad-sales growth driving....
These 3 Stocks Are Priced for Perfection. Can They Deliver?
These 3 Stocks Are Priced for Perfection. Can They Deliver?
You expect a top-ranked football team to play well every game. You expect the Kentucky Derby winner to place in the Preakness Stakes. And you expect a stock with a high valuation to generate....
Better Buy: Celgene Corporation vs. Merck & Co., Inc.
Better Buy: Celgene Corporation vs. Merck & Co., Inc.
Based on recent history, Celgene Corporation (NASDAQ: CELG) and Merck & Co. (NYSE: MRK) stocks don't even belong in the same league. Celgene stock is up more than 270% over the past five....
Better Buy: Celgene Corporation vs. Merck & Co., Inc.
Better Buy: Celgene Corporation vs. Merck & Co., Inc.
Based on recent history, Celgene Corporation (NASDAQ: CELG) and Merck & Co. (NYSE: MRK) stocks don't even belong in the same league. Celgene stock is up more than 270% over the past five....
What Went Wrong With Toys R Us
What Went Wrong With Toys R Us
In the 1980s and even the 1990s, Toys R Us was a destination that children begged their parents to take them to.The chain had a selection of toys that dwarfed what was sold at now-defunct....
What Went Wrong With Toys R Us
What Went Wrong With Toys R Us
In the 1980s and even the 1990s, Toys R Us was a destination that children begged their parents to take them to.The chain had a selection of toys that dwarfed what was sold at now-defunct....
What Went Wrong With Toys R Us
What Went Wrong With Toys R Us
In the 1980s and even the 1990s, Toys R Us was a destination that children begged their parents to take them to.The chain had a selection of toys that dwarfed what was sold at now-defunct....

	 
DNXCORP (ex DREAMNEX) : CP DNX corp : Mise à disposition du rapport financier du premier semestre 2017
DNXCORP (ex DREAMNEX) : CP DNX corp : Mise à disposition du rapport financier du premier semestre 2017
COMMUNIQUE DE PRESSE Luxembourg, le 21 septembre 2017 Mise à disposition du rapport financier du premier semestre 2017 DNXcorp annonce que son rapport financier pour le premier semestre 2017....
Eddie Lampert Makes More Smart Brand Deals for Sears Holdings. Does It Matter?
Eddie Lampert Makes More Smart Brand Deals for Sears Holdings. Does It Matter?
The deals CEO Eddie Lampert has made for Sears Holdings Corp (NASDAQ: SHLD) in 2017 show what a crying shame it is he wasn't as innovative earlier.Sears recently announced two more deals for its....
Auswertung Musterdepot KW 38/17
Auswertung Musterdepot KW 38/17
Auswertung Musterdepot KW 38/17 Musterdepot Seit Auflage des Musterdepots am 16.06.2017 hat das Musterdepot einen Gewinn von 0,5 Prozent eingefahren. Die Anfangssumme von 100.000 € wurde zu 38,6....
Tesla Inc (TSLA) Stock Rides On Its Tech, So What If Its Claims Are “Exaggerated”?
Tesla Inc (TSLA) Stock Rides On Its Tech, So What If Its Claims Are “Exaggerated”?
At this point, the biggest reason investors buy Tesla Inc (TSLA) stock, especially given how high it is relative to the company’s fundamentals, is the company’s technology. But what if Tesla....